pancreatic cancer
Showing NaN - NaN of 56
Non Small Cell Lung Cancer, Colorectal Cancer, Pancreatic Cancer Trial in United States (GRT-C903, GRT-R904, nivolumab)
Recruiting
- Non-Small Cell Lung Cancer
- +4 more
- GRT-C903
- +3 more
-
Phoenix, Arizona
- +13 more
Jan 30, 2023
Pancreatic Cancer, Pancreas Cancer, Pancreatic Diseases Trial in Canada, United States (Cefoxitin, Piperacillin-tazobactam)
Active, not recruiting
- Pancreatic Cancer
- +2 more
-
Sacramento, California
- +31 more
Jan 12, 2023
Biomarkers in Subjects With Untreated Solid Tumors
Completed
- Breast Cancer
- +12 more
- Blood Sample Collection
-
Phoenix, Arizona
- +118 more
Aug 31, 2022
Pancreatic Adenosquamous Carcinoma, Resectable Pancreatic Adenocarcinoma, Pancreatic Cancer Trial in United States (drug,
Recruiting
- Pancreatic Adenosquamous Carcinoma
- +2 more
- Oxaliplatin
- +5 more
-
Mobile, Alabama
- +182 more
Aug 1, 2022
NSCLC, Renal Cell Cancer, Colorectal Cancer Trial in Australia, United States (CPI-006, CPI-006 + ciforadenant, CPI-006 +
Active, not recruiting
- Non-Small Cell Lung Cancer
- +12 more
- CPI-006
- +2 more
-
Tucson, Arizona
- +26 more
Aug 1, 2022
Pancreatic Cancer Trial in Chicago (Lidocaine Hydrochloride, Saline Solution for Injection)
Recruiting
- Pancreatic Cancer
- Lidocaine Hydrochloride
- Saline Solution for Injection
-
Chicago, IllinoisUniversity of Illnois at Chicago
Apr 8, 2022
Advanced Solid Tumors, Head Neck Cancer, Pancreatic Cancer Trial in United States (Cabiralizumab, Nivolumab)
Completed
- Advanced Solid Tumors
- +6 more
- Cabiralizumab
- Nivolumab
-
Scottsdale, Arizona
- +38 more
Jan 5, 2022
Pancreatic Cancer Trial in United States (Directional Brachytherapy Source Implant)
Recruiting
- Pancreatic Cancer
- Directional Brachytherapy Source Implant
-
Chicago, Illinois
- +4 more
Mar 1, 2022
Liver Cancer, Anxiety Disorder, Depression Trial in United States (Early palliative care)
Completed
- Liver Cancer
- +9 more
- Early palliative care
-
La Jolla, California
- +22 more
Jul 22, 2021
Pancreatic Cancer Trial in Chicago (Stereotactic Radiation)
Active, not recruiting
- Pancreatic Cancer
- Stereotactic Radiation
-
Chicago, IllinoisUniversity of Chicago
Mar 26, 2021
Multi-Media Tool on Enrollment in Oncology Clinical Trials
Completed
- Lung Cancer
- +2 more
- Testing an interactive technology in a diverse health literary population
-
Chicago, IllinoisUniversity of Chicago Comprehensive Cancer Center
Mar 8, 2021
Pancreatic Cancer Trial in United States (HyperAcute(R)-Pancreatic Cancer Vaccine)
Completed
- Pancreatic Cancer
- HyperAcute(R)-Pancreatic Cancer Vaccine
-
Scottsdale, Arizona
- +17 more
May 26, 2020
Pancreatic Cancer Trial in Chicago (HyperAcute-Pancreatic Cancer Vaccine)
Completed
- Pancreatic Cancer
- HyperAcute-Pancreatic Cancer Vaccine
-
Chicago, IllinoisNorthwestern University
May 26, 2020
Pancreatic Cancer Trial in United States (biological, drug, radiation)
Completed
- Pancreatic Cancer
- HyperAcute-Pancreas Immunotherapy
- +2 more
-
Birmingham, Alabama
- +74 more
May 26, 2020
Pancreatic Cancer Trial in Worldwide (Ruxolitinib, Placebo, Capecitabine)
NSCLC, Breast Cancer, Pancreatic Cancer Trial in United States (Ibrutinib, Durvalumab)
Completed
- Non-Small Cell Lung Cancer
- +2 more
-
Birmingham, Alabama
- +16 more
Dec 7, 2018
Pancreatic Cancer Trial in Chicago (biological, drug, procedure, radiation)
Completed
- Pancreatic Cancer
- bevacizumab
- +3 more
-
Chicago, IllinoisNorthwestern University
Oct 25, 2018
Pancreatic Cancer Trial in Chicago, Houston (Dolastatin 10)
Completed
- Pancreatic Cancer
- Dolastatin 10
-
Chicago, Illinois
- +1 more
Oct 23, 2018
Pancreatic Cancer, Adenocarcinoma, Pancreatic Tumors Trial in San Francisco, Chicago, Madison (FOLFIRINOX, IPI-926)
Completed
- Pancreatic Cancer
- +2 more
- FOLFIRINOX, IPI-926
-
San Francisco, California
- +2 more
Aug 7, 2017
Bladder Cancer, Breast Cancer, Colorectal Cancer Trial in Chicago (gemcitabine HCl, irinotecan HCl)
Completed
- Bladder Cancer
- +5 more
- gemcitabine hydrochloride
- irinotecan hydrochloride
-
Chicago, IllinoisRobert H. Lurie Comprehensive Cancer Center at Northwestern Univ
Apr 14, 2017